For instance, in the RV144 trial, CD4+ T-cells secreting IL-2, TNF-α, IFN-γ, IL-4, and CD154 in response to HIV-1 envelope peptides were associated with lower infection rates in vaccine recipients [57]. This evidence concerns the gene CD40LG and infection.